Artículos Científicos

Editor: NOEL GONZÁLEZ GOTERA Número 090 Diseño: Lic. Roberto Chávez y Liuder Machado. Semana 290613 – 050713 Foto: Lic. Belkis Romeu e Instituto Finlay La Habana, Cuba.

ARTÍCULOS CIENTÍFICOS

Publicaciones incluidas en PubMED durante el período comprendido entre el 29 de junio y el 5 de julio de 2013. Con “vaccin*” en título: 109 artículos recuperados.

Vacunas Meningococo (Neisseria meningitidis)

29. Quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine (MenACWY-TT): a review.

Ghanem S, Hassan S, Saad R, Dbaibo GS.

Expert Opin Biol Ther. 2013 Jul 2. [Epub ahead of print]

PMID: 23815506 [PubMed - as supplied by publisher]

Related citations

Select item 23815273

45. Persistence of antibodies in adolescents 18-24 mo after immunization with one, two or three doses of 4CMenB meningococcal serogroup B vaccine.

Elena Santolaya M, O'Ryan M, Teresa Valenzuela M, Prado V, Vergara RF, Muñoz A, Toneatto D, Graña G, Wang H, Dull PM.

Hum Vaccin Immunother. 2013 Jun 28;9(11). [Epub ahead of print]

PMID: 23811804 [PubMed - as supplied by publisher]

Related citations

Select item 23811786

Vacunas Neumococo (Streptococcus pneumoniae)

1. Pneumococcal Conjugate Vaccine: Are 3 Doses Equal to 4 Doses?

Walter EB, Clements DA.

Pediatrics. 2013 Jul 1. [Epub ahead of print] No abstract available.

PMID: 23821696 [PubMed - as supplied by publisher]

Related citations

Select item 23821695

2. Cost-Effectiveness of Using 2 vs 3 Primary Doses of 13-Valent Pneumococcal Conjugate Vaccine.

Stoecker C, Hampton LM, Link-Gelles R, Messonnier ML, Zhou F, Moore MR.

Pediatrics. 2013 Jul 1. [Epub ahead of print]

PMID: 23821695 [PubMed - as supplied by publisher]

Related citations

Select item 23821446

18. Perception about influenza and pneumococcal vaccines and vaccination coverage among patients with malignancies and their family members.

Urun Y, Akbulut H, Demirkazik A, Cay Senler F, Utkan G, Onur H, Icli F.

J BUON. 2013 Apr-Jun;18(2):511-515.

PMID: 23818370 [PubMed - as supplied by publisher]

Related citations

Select item 23818263

40. Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: Tailoring better vaccination strategies.

Rosado MM, Gesualdo F, Marcellini V, Di Sabatino A, Corazza GR, Smacchia MP, Nobili B, Baronci C, Russo L, Rossi F, De Vito R, Nicolosi L, Inserra A, Locatelli F, Tozzi AE, Carsetti R.

Eur J Immunol. 2013 Jun 28. doi: 10.1002/eji.201343577. [Epub ahead of print]

PMID: 23813052 [PubMed - as supplied by publisher]

Related citations 2

59. The potential for pneumococcal vaccination in Hajj pilgrims: Expert opinion.

Rashid H, Abdul Muttalif AR, Mohamed Dahlan ZB, Djauzi S, Iqbal Z, Karim HM, Naeem SM, Tantawichien T, Zotomayor R, Patil S, Schmitt HJ.

Travel Med Infect Dis. 2013 Jun 27. doi:pii: S1477-8939(13)00094-X. 10.1016/j.tmaid.2013.06.001. [Epub ahead of print]

PMID: 23810307 [PubMed - as supplied by publisher]

Related citations

Select item 23810252

90. Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults.

Smith KJ, Nowalk MP, Raymund M, Zimmerman RK.

Vaccine. 2013 Jun 24. doi:pii: S0264-410X(13)00815-3. 10.1016/j.vaccine.2013.06.037. [Epub ahead of print]

PMID: 23806240 [PubMed - as supplied by publisher]

Related citations

Select item 23806224

93. [Experience of application of pneumococcus vaccines for studies of humoral immunity].

[No authors listed]

Zh Mikrobiol Epidemiol Immunobiol. 2013 Mar-Apr;(2):96-101. Russian.

PMID: 23805679 [PubMed - in process]

Related citations

Select item 23805659

102. What do policy makers need to know? Lessons from the decision to add pneumococcal conjugate and rotavirus vaccines to the US immunization program.

Whitney CG, Parashar UD.

Vaccine. 2013 Jul 2;31 Suppl 3:C6-7. doi: 10.1016/j.vaccine.2013.05.051. No abstract available.

PMID: 23777693 [PubMed - in process]

Related citations

Select item 23777690

Vacuna Tosferina (Bordetella pertussis)

3. [Pertussis vaccination coverage among adults in Germany.]

Böhmer MM, Hellenbrand W, Matysiak-Klose D, Heininger U, Müters S, Wichmann O.

Dtsch Med Wochenschr. 2013 Jul;138(28/29):1451-1457. Epub 2013 Jul 2. German.

PMID: 23821446 [PubMed - as supplied by publisher]

Related citations

Select item 23820860

44. Committee opinion no. 566: update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination.

[No authors listed]

Obstet Gynecol. 2013 Jun;121(6):1411-4. doi: 10.1097/01.AOG.0000431054.33593.e3.

PMID: 23812487 [PubMed - in process]

Related citations

Select item 23811804

Vacuna Tuberculosis (Mycobacterium tuberculosis)

66. Tuberculosis vaccine trials - Authors' reply.

Tameris M, Hatherill M, Mahomed H, McShane H.

Lancet. 2013 Jun 29;381(9885):2254. doi: 10.1016/S0140-6736(13)61483-X. No abstract available.

PMID: 23809562 [PubMed - in process]

Related citations

Select item 23809561

67. Tuberculosis vaccine trials.

Upadhyay P.

Lancet. 2013 Jun 29;381(9885):2253-4. doi: 10.1016/S0140-6736(13)61482-8. No abstract available.

PMID: 23809561 [PubMed - in process]

Related citations

Select item 23809560

67. Tuberculosis vaccine trials.

Upadhyay P.

Lancet. 2013 Jun 29;381(9885):2253-4. doi: 10.1016/S0140-6736(13)61482-8. No abstract available.

PMID: 23809561 [PubMed - in process]

Related citations

Select item 23809560

68. Tuberculosis vaccine trials.

Behr MA, Schwartzman K, Pai M.

Lancet. 2013 Jun 29;381(9885):2252-3. doi: 10.1016/S0140-6736(13)61481-6. No abstract available.

PMID: 23809560 [PubMed - in process]

Related citations

Select item 23809262

108. Effectiveness of the 7-valent pneumococcal conjugate vaccine against vaccine-type invasive disease among children in Uruguay: An evaluation using existing data.

Picón T, Alonso L, García Gabarrot G, Speranza N, Casas M, Arrieta F, Camou T, Rosa R, Helena De Oliveira L, Verani JR.

Vaccine. 2013 Jul 2;31 Suppl 3:C109-13. doi: 10.1016/j.vaccine.2013.01.059.

PMID: 23777683 [PubMed - in process]

Related citations

Select item 23777682

Vacunas, otras

Pneumococcal Conjugate Vaccine: Are 3 Doses Equal to 4 Doses?

Walter EB, Clements DA.

Pediatrics. 2013 Jul 1. [Epub ahead of print] No abstract available.

PMID: 23821696

[PubMed - as supplied by publisher]

Related citations

Select item 23821695 2.

Cost-Effectiveness of Using 2 vs 3 Primary Doses of 13-Valent Pneumococcal Conjugate Vaccine.

Stoecker C, Hampton LM, Link-Gelles R, Messonnier ML, Zhou F, Moore MR.

Pediatrics. 2013 Jul 1. [Epub ahead of print]

PMID: 23821695 [PubMed - as supplied by publisher]

Related citations

Select item 23821446 3.

[Pertussis vaccination coverage among adults in Germany.]

Böhmer MM, Hellenbrand W, Matysiak-Klose D, Heininger U, Müters S, Wichmann O.

Dtsch Med Wochenschr. 2013 Jul;138(28/29):1451-1457. Epub 2013 Jul 2. German.

PMID: 23821446 [PubMed - as supplied by publisher]

Related citations

Select item 23820860 4.

Vaccinations in juvenile chronic inflammatory diseases: an update.

Silva CA, Aikawa NE, Bonfa E.

Nat Rev Rheumatol. 2013 Jul 2. doi: 10.1038/nrrheum.2013.95. [Epub ahead of print]

PMID: 23820860 [PubMed - as supplied by publisher]

Related citations

Select item 23820782 5.

Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. 6

Furman D, Jojic V, Kidd B, Shen-Orr S, Price J, Jarrell J, Tse T, Huang H, Lund P, Maecker HT, Utz PJ, Dekker CL, Koller D, Davis MM.

Mol Syst Biol. 2013 Jul 2;9:680. doi: 10.1038/msb.2013.37. No abstract available.

PMID: 23820782 [PubMed - as supplied by publisher]

Related citations

Select item 23820750 6.

Imaging murine NALT following intranasal immunization with flagellin-modified circumsporozoite protein malaria vaccines.

Nacer A, Carapau D, Mitchell R, Meltzer A, Shaw A, Frevert U, Nardin EH.

Mucosal Immunol. 2013 Jul 3. doi: 10.1038/mi.2013.48. [Epub ahead of print]

PMID: 23820750 [PubMed - as supplied by publisher]

Related citations

Select item 23820294 7.

Vaccination with Vaxfectin (®) adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia.

Kulkarni V, Rosati M, Valentin A, Jalah R, Alicea C, Yu L, Guan Y, Shen X, Tomaras GD, Labranche C, Montefiori DC, Irene C, Prattipati R, Pinter A, Sullivan SM, Pavlakis GN, Felber BK.

Hum Vaccin Immunother. 2013 Jul 2;9(10). [Epub ahead of print]

PMID: 23820294 [PubMed - as supplied by publisher]

Related citations

Select item 23820238 8.

Cycling probe technology to quantify and discriminate between wild-type varicella- zoster virus and Oka vaccine strains.

Ihira M, Higashimoto Y, Kawamura Y, Sugata K, Ohashi M, Asano Y, Yoshikawa T.

J Virol Methods. 2013 Jun 29. doi:pii: S0166-0934(13)00245-0. 10.1016/j.jviromet.2013.06.031. [Epub ahead of print]

PMID: 23820238 [PubMed - as supplied by publisher]

Related citations

Select item 23820080 9.

Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States.

Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE.

Vaccine. 2013 Jun 29. doi:pii: S0264-410X(13)00842-6. 10.1016/j.vaccine.2013.06.050. [Epub ahead of print]

PMID: 23820080 [PubMed - as supplied by publisher]

Related citations

Select item 23820079 10.

Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice.

Venter M, van Vuren PJ, Mentoor J, Paweska J, Williams J.

Vaccine. 2013 Jun 29. doi:pii: S0264-410X(13)00851-7. 10.1016/j.vaccine.2013.06.059. [Epub ahead of print]

PMID: 23820079 [PubMed - as supplied by publisher]

Related citations

Select item 23819789 11.

The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia.

Uusküla A, Müürsepp A, Kawai K, Raag M, Jürisson M, Pillsbury M.

BMC Infect Dis. 2013 Jul 3;13(1):304. [Epub ahead of print]

PMID: 23819789 [PubMed - as supplied by publisher]

Related citations

Select item 23819648 12.

Synthesis and Vaccine Evaluation of the Tumor Associated Carbohydrate Antigen RM2 from Prostate Cancer.

Chuang HY, Ren CT, Chao CA, Wu CY, Shivatare SS, Cheng TJ, Wu CY, Wong CH.

J Am Chem Soc. 2013 Jul 2. [Epub ahead of print]

PMID: 23819648 [PubMed - as supplied by publisher]

Related citations

Select item 23819514 13.

Promoting Universal Vaccination Among Workers.

[No authors listed]

Workplace Health Saf. 2013 Jul 1;61(7):323. doi: 10.3928/21650799-20130624-29. No abstract available.

PMID: 23819514 [PubMed - as supplied by publisher]

Related citations

Select item 23818856 14.

Dissection of Antibody Specificities Induced by Yellow Fever Vaccination.

Vratskikh O, Stiasny K, Zlatkovic J, Tsouchnikas G, Jarmer J, Karrer U, Roggendorf M, Roggendorf H, Allwinn R, Heinz FX.

PLoS Pathog. 2013 Jun;9(6):e1003458. Epub 2013 Jun 20.

PMID: 23818856 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 23818843 15.

HIV-1 Vaccine-Induced T-Cell Reponses Cluster in Epitope Hotspots that Differ from Those Induced in Natural Infection with HIV-1.

Hertz T, Ahmed H, Friedrich DP, Casimiro DR, Self SG, Corey L, McElrath MJ, Buchbinder S, Horton H, Frahm N, Robertson MN, Graham BS, Gilbert P.

PLoS Pathog. 2013 Jun;9(6):e1003404. Epub 2013 Jun 20.

PMID: 23818843 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 23818801 16.

Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient Sample.

Stobaugh DJ, Deepak P, Ehrenpreis ED.

Clin Exp Gastroenterol. 2013 May 6;6:43-9. doi: 10.2147/CEG.S42514. Print 2013.

PMID: 23818801 [PubMed - in process] Free Article

Related citations

Select item 23818778 17.

Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery.

Petersen LK, Huntimer L, Walz K, Ramer-Tait A, Wannemuehler MJ, Narasimhan B.

Int J Nanomedicine. 2013;8:2213-2225. Epub 2013 Jun 18.

PMID: 23818778 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 23818370 18.

Perception about influenza and pneumococcal vaccines and vaccination coverage among patients with malignancies and their family members.

Urun Y, Akbulut H, Demirkazik A, Cay Senler F, Utkan G, Onur H, Icli F.

J BUON. 2013 Apr-Jun;18(2):511-515.

PMID: 23818370 [PubMed - as supplied by publisher]

Related citations

Select item 23818263 19.

High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.

Campos LM, Silva CA, Aikawa NE, Jesus AA, Moraes JC, Miraglia J, Ishida MA, Bueno C, Pereira RM, Bonfa E.

Arthritis Care Res (Hoboken). 2013 Jul;65(7):1121-7. doi: 10.1002/acr.21948.

PMID: 23818263 [PubMed - in process]

Related citations

Select item 23817721 20.

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma.

Vik-Mo EO, Nyakas M, Mikkelsen BV, Moe MC, Due-Tønnesen P, Suso EM, Sæbøe- Larssen S, Sandberg C, Brinchmann JE, Helse

Select item 23817336 21.

Community Diarrhea Incidence Before and After Rotavirus Vaccine Introduction in Nicaragua.

Becker-Dreps S, Meléndez M, Liu L, Enrique Zambrana L, Paniagua M, Weber DJ, Hudgens MG, Cáceres M, Källeståll C, Morgan DR, Espinoza F, Peña R.

Am J Trop Med Hyg. 2013 Jul 1. [Epub ahead of print]

PMID: 23817336 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 23817319 22.

Human vaccines & immunotherapeutics: news.

Riedmann EM.

Hum Vaccin Immunother. 2012 Dec 1;8(12):1741-4. doi: 10.4161/hv.23373.

PMID: 23817319 [PubMed - in process] Free Article

Related citations

Select item 23816608 23.

Double-deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumors.

Lun X, Ruan Y, Jayanthan A, Liu DJ, Singh A, Trippett T, Bell J, Forsyth P, Johnston RN, Narendran A.

Mol Oncol. 2013 Jun 14. doi:pii: S1574-7891(13)00083-5. 10.1016/j.molonc.2013.05.004. [Epub ahead of print]

PMID: 23816608 [PubMed - as supplied by publisher]

Related citations

Select item 23816434 24.

Role of the vaccinia virus O3 protein in cell entry can be fulfilled by its Sequence flexible transmembrane domain.

Satheshkumar PS, Chavre J, Moss B.

Virology. 2013 Jun 28. doi:pii: S0042-6822(13)00352-8. 10.1016/j.virol.2013.06.003. [Epub ahead of print]

PMID: 23816434 [PubMed - as supplied by publisher]

Related citations

Select item 23816301 25.

Enhancement of humoral and cellular immune responses by monophosphoryl lipid A (MPLA) as an adjuvant to the rabies vaccine in BALB/c mice.

Hu X, Liu R, Zhu N.

Immunobiology. 2013 May 30. doi:pii: S0171-2985(13)00112-5. 10.1016/j.imbio.2013.05.006. [Epub ahead of print]

PMID: 23816301 [PubMed - as supplied by publisher]

Related citations

Select item 23815619 26.

Evaluation of the adjuvant effect of Salmonella-based Escherichia coli heat-labile toxin B subunits on the efficacy of a live Salmonella-delivered avian pathogenic Escherichia coli vaccine.

Chaudhari AA, Lee JH.

Avian Pathol. 2013 Jun 11. [Epub ahead of print]

PMID: 23815619 [PubMed - as supplied by publisher]

Related citations

Select item 23815523 27.

Varicella routine vaccination and the effects on varicella epidemiology -- results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011.

Streng A, Grote V, Carr D, Hagemann C, Liese JG.

BMC Infect Dis. 2013 Jul 2;13(1):303. [Epub ahead of print]

PMID: 23815523 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 23815510 28.

Determination of vaccination status of pregnant women during pregnancy and the affecting factors.

Celikel A, Ustunsoz A, Guvenc G.

J Clin Nurs. 2013 Jul 2. doi: 10.1111/jocn.12351. [Epub ahead of print]

PMID: 23815510 [PubMed - as supplied by publisher]

Related citations

Select item 23815506 29.

Quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine (MenACWY-TT): a review.

Ghanem S, Hassan S, Saad R, Dbaibo GS.

Expert Opin Biol Ther. 2013 Jul 2. [Epub ahead of print]

PMID: 23815506 [PubMed - as supplied by publisher]

Related citations

Select item 23815273 30.

Modeling the public health impact of malaria vaccines for developers and policymakers.

Nunes JK, Cárdenas V, Loucq C, Maire N, Smith T, Shaffer C, Måseide K, Brooks A.

BMC Infect Dis. 2013 Jul 1;13(1):295. [Epub ahead of print]

PMID: 23815273 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 23815079 31.

Environmental persistence of vaccinia virus on materials.

Wood JP, Choi YW, Wendling MQ, Rogers JV, Chappie DJ.

Lett Appl Microbiol. 2013 Jul 1. doi: 10.1111/lam.12126. [Epub ahead of print]

PMID: 23815079 [PubMed - as supplied by publisher]

Related citations

Select item 23815072 32.

Jenner-predict server: prediction of protein vaccine candidates (PVCs) in bacteria based on host-pathogen interactions.

Jaiswal V, Chanumolu SK, Gupta A, Chauhan RS, Rout C.

BMC Bioinformatics. 2013 Jul 1;14(1):211. [Epub ahead of print]

PMID: 23815072 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 23814696 33.

A Recombinant Adenovirus Encoding Multiple HIV-1 Epitopes Induces Stronger CD4⁺ T cell Responses than a DNA Vaccine in Mice.

Rosa DS, Ribeiro SP, Almeida RR, Mairena EC, Kalil J, Cunha-Neto E.

J Vaccines Vaccin. 2011 Dec 2;2(4). doi:pii: 1000124.

PMID: 23814696 [PubMed]

Related citations

Select item 23814353 34.

In vivo evaluation of vaccine efficacy against challenge with a contemporary field isolate from the α cluster of H1N1 swine influenza virus.

Detmer SE, Gramer MR, King VL, Mathur S, Rapp-Gabrielson VJ.

Can J Vet Res. 2013 Jan;77(1):24-32.

PMID: 23814353 [PubMed - in process]

Related citations

Select item 23813811 35.

Matrix Vaccination Guidelines: ABCD recommendations for indoor/ outdoor cats, rescue shelter cats and breeding catteries.

Hosie MJ, Addie D, Belák S, Boucraut-Baralon C, Egberink H, Frymus T, Gruffydd-Jones T, Hartmann K, Lloret A, Lutz H, Marsilio F, Möstl K, Pennisi MG, Radford AD, Thiry E, Truyen U, Horzinek MC.

J Feline Med Surg. 2013 Jul;15(7):540-4. doi: 10.1177/1098612X13489209.

PMID: 23813811 [PubMed - in process]

Related citations

Select item 23813706 36.

Kicking against the pricks: vaccine sceptics have a different social orientation.

Luyten J, Desmet P, Dorgali V, Hens N, Beutels P.

Eur J Public Health. 2013 Jun 28. [Epub ahead of print]

PMID: 23813706 [PubMed - as supplied by publisher]

Related citations

Select item 23813313 37.

Inhalational anthrax in a vaccinated soldier.

Sykes A, Brooks T, Dusmet M, Nicholson AG, Hansell DM, Wilson R.

Eur Respir J. 2013 Jul;42(1):285-7. doi: 10.1183/09031936.00201112. No abstract available.

PMID: 23813313 [PubMed - in process]

Related citations

Select item 23813283 38.

Case-only method for cause-specific hazards models with application to assessing differential vaccine efficacy by viral and host genetics.

Dai JY, Li SS, Gilbert PB.

Biostatistics. 2013 Jun 27. [Epub ahead of print]

PMID: 23813283 [PubMed - as supplied by publisher]

Related citations

Select item 23813248 39.

Molecular characteristics and evolutionary analysis of field Marek's disease virus prevalent in vaccinated chicken flocks in recent years in China.

Yu ZH, Teng M, Luo J, Wang XW, Ding K, Yu LL, Su JW, Chi JQ, Zhao P, Hu B, Zhang GP, Liu JX.

Virus Genes. 2013 Jun 29. [Epub ahead of print]

PMID: 23813248 [PubMed - as supplied by publisher]

Related citations

Select item 23813052 40.

Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: Tailoring better vaccination strategies.

Rosado MM, Gesualdo F, Marcellini V, Di Sabatino A, Corazza GR, Smacchia MP, Nobili B, Baronci C, Russo L, Rossi F, De Vito R, Nicolosi L, Inserra A, Locatelli F, Tozzi AE, Carsetti R.

Eur J Immunol. 2013 Jun 28. doi: 10.1002/eji.201343577. [Epub ahead of print]

PMID: 23813052 [PubMed - as supplied by publisher]

Related citations

Select item 23812806 41.

Development of diagnostic and vaccine markers through cloning, expression, and regulation of putative virulence-protein-encoding genes of Aeromonas hydrophila.

Singh V, Chaudhary DK, Mani I, Jain R, Mishra BN.

J Microbiol. 2013 Jun;51(3):275-82. doi: 10.1007/s12275-013-2437-x. Epub 2013 Jun 28.

PMID: 23812806 [PubMed - in process]

Related citations

Select item 23812794 42.

Hepatitis B vaccination of men who have sex with men in the Netherlands: should we vaccinate more men, younger men or high-risk men?

Xiridou M, van Houdt R, Hahné S, Coutinho R, van Steenbergen J, Kretzschmar M.

Sex Transm Infect. 2013 Jun 29. [Epub ahead of print]

PMID: 23812794 [PubMed - as supplied by publisher]

Related citations

Select item 23812513 43.

Randomized controlled trial of topical EMLA and breastfeeding for reducing pain during wDPT vaccination.

Gupta NK, Upadhyay A, Agarwal A, Goswami G, Kumar J, Sreenivas V.

Eur J Pediatr. 2013 Jun 29. [Epub ahead of print]

PMID: 23812513 [PubMed - as supplied by publisher]

Related citations

Select item 23812487 44.

Committee opinion no. 566: update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination.

[No authors listed]

Obstet Gynecol. 2013 Jun;121(6):1411-4. doi: 10.1097/01.AOG.0000431054.33593.e3.

PMID: 23812487

[PubMed - in process]

Related citations

Select item 23811804 45.

Persistence of antibodies in adolescents 18-24 mo after immunization with one, two or three doses of 4CMenB meningococcal serogroup B vaccine.

Elena Santolaya M, O'Ryan M, Teresa Valenzuela M, Prado V, Vergara RF, Muñoz A, Toneatto D, Graña G, Wang H, Dull PM.

Hum Vaccin Immunother. 2013 Jun 28;9(11). [Epub ahead of print]

PMID: 23811804 [PubMed - as supplied by publisher]

Related citations

Select item 23811786 46.

Story and science: How providers and parents can utilize storytelling to combat anti- vaccine misinformation.

Shelby A, Ernst K.

Hum Vaccin Immunother. 2013 Jun 28;9(8). [Epub ahead of print]

PMID: 23811786 [PubMed - as supplied by publisher]

Related citations

Select item 23811746 47.

Effectiveness of Haemophilus influenzae Type b Vaccines Administered According to Various Schedules: Systematic Review and Meta-Analysis of Observational Data.

Jackson C, Mann A, Mangtani P, Fine P.

Pediatr Infect Dis J. 2013 Jun 27. [Epub ahead of print]

PMID: 23811746 [PubMed - as supplied by publisher]

Related citations

Select item 23811610 48.

Field seasonal influenza vaccine effectiveness: Evaluation of the screening method using different sources of data during the 2010/2011 French influenza season.

Falchi A, Souty C, Grisoni ML, Mosnier A, Hanslik T, Daviaud I, Varesi L, Kerneis S, Carrat F, Blanchon T.

Hum Vaccin Immunother. 2013 Jun 28;9(11). [Epub ahead of print]

PMID: 23811610 [PubMed - as supplied by publisher]

Related citations

Select item 23811550 49.

Immunogenicity of a New Recombinant IpaC from Shigella dysenteriae Type I in Guinea Pig as a Vaccine Candidate.

Malaei F, Hesaraki M, Saadati M, Ahdi AM, Sadraeian M, Honari H, Nazarian S.

Iran J Immunol. 2013 Jun;10(2):110-7. doi: IJIv10i2A6.

PMID: 23811550 [PubMed - in process]

Related citations

Select item 23811421 50.

Microfluidic devices for continuous production of pDNA/cationic liposome complexes for gene delivery and vaccine therapy.

Balbino TA, Azzoni AR, de la Torre LG.

Colloids Surf B Biointerfaces. 2013 Apr 15;111C:203-210. doi: 10.1016/j.colsurfb.2013.04.003. [Epub ahead of print]

PMID: 23811421 [PubMed - as supplied by publisher]

Related citations

Select item 23811402 51.

Cytomegalovirus-based cancer vaccines expressing TRP2 induce rejection of melanoma in mice.

Xu G, Smith T, Grey F, Hill AB.

Biochem Biophys Res Commun. 2013 Jun 27. doi:pii: S0006-291X(13)01066-8. 10.1016/j.bbrc.2013.06.068. [Epub ahead of print]

PMID: 23811402 [PubMed - as supplied by publisher]

Related citations

Select item 23811351 52.

The major fimbrial subunit protein of Edwardsiella tarda: Vaccine potential, adjuvant effect, and involvement in host infection.

Wang C, Hu YH, Chi H, Sun L.

Fish Shellfish Immunol. 2013 Jun 27. doi:pii: S1050-4648(13)00616-5. 10.1016/j.fsi.2013.06.021. [Epub ahead of print]

PMID: 23811351 [PubMed - as supplied by publisher]

Related citations

Select item 23811052 53.

Vaccine potential of recombinant cathepsin B against Fasciola gigantica.

Chantree P, Phatsara M, Meemon K, Chaichanasak P, Changklungmoa N, Kueakhai P, Lorsuwannarat N, Sangpairoj K, Songkoomkrong S, Wanichanon C, Itagaki T, Sobhon P.

Exp Parasitol. 2013 Jun 26. doi:pii: S0014-4894(13)00168-9. 10.1016/j.exppara.2013.06.010. [Epub ahead of print]

PMID: 23811052 [PubMed - as supplied by publisher]

Related citations

Select item 23810586 54.

Intake of specific fatty acids and fat alters growth, health, and titers following vaccination in dairy calves.

Esselburn KM, O'Diam KM, Hill TM, Bateman HG 2nd, Aldrich JM, Schlotterbeck RL, Daniels KM.

J Dairy Sci. 2013 Jun 27. doi:pii: S0022-0302(13)00460-8. 10.3168/jds.2013-6608. [Epub ahead of print]

PMID: 23810586 [PubMed - as supplied by publisher]

Related citations

Select item 23810525 55.

[An experience of the use of cell culture-derived influenza vaccines in an influenza vaccination campaign.]

Pérez-Rubio A, Bouza JM.

Gac Sanit. 2013 Jun 27. doi:pii: S0213-9111(13)00097-6. 10.1016/j.gaceta.2013.05.003. [Epub ahead of print] Spanish. No abstract available.

PMID: 23810525 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 23810375 56.

Anti-HBs evaluation and booster dose in vaccinated healthcare students.

Riva MA, Sormani M.

Vaccine. 2013 Jun 26. doi:pii: S0264-410X(13)00783-4. 10.1016/j.vaccine.2013.06.014. [Epub ahead of print] No abstract available.

PMID: 23810375 [PubMed - as supplied by publisher]

Related citations

Select item 23810374 57.

Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Hong Kong SAR, China, 24-26 January 2013.

Girard MP, Tam JS, Pervikov Y, Katz JM.

Vaccine. 2013 Jun 26. doi:pii: S0264-410X(13)00837-2. 10.1016/j.vaccine.2013.06.047. [Epub ahead of print]

PMID: 23810374 [PubMed - as supplied by publisher]

Related citations

Select item 23810308 58.

Epidemiology and impact of varicella vaccination: A longitudinal study 1994-2011.

Al-Tawfiq JA, Abukhamsin A, Memish ZA.

Travel Med Infect Dis. 2013 Jun 27. doi:pii: S1477-8939(13)00095-1. 10.1016/j.tmaid.2013.06.002. [Epub ahead of print]

PMID: 23810308 [PubMed - as supplied by publisher]

Related citations

Select item 23810307 59.

The potential for pneumococcal vaccination in Hajj pilgrims: Expert opinion.

Rashid H, Abdul Muttalif AR, Mohamed Dahlan ZB, Djauzi S, Iqbal Z, Karim HM, Naeem SM, Tantawichien T, Zotomayor R, Patil S, Schmitt HJ.

Travel Med Infect Dis. 2013 Jun 27. doi:pii: S1477-8939(13)00094-X. 10.1016/j.tmaid.2013.06.001. [Epub ahead of print]

PMID: 23810307 [PubMed - as supplied by publisher]

Related citations

Select item 23810252 60.

Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.

Kwong JC, Vasa PP, Campitelli MA, Hawken S, Wilson K, Rosella LC, Stukel TA, Crowcroft NS, McGeer AJ, Zinman L, Deeks SL.

Lancet Infect Dis. 2013 Jun 27. doi:pii: S1473-3099(13)70104-X. 10.1016/S1473- 3099(13)70104-X. [Epub ahead of print]

PMID: 23810252 [PubMed - as supplied by publisher]

Related citations

Select item 23810251 61.

Association between vaccination and Guillain-Barré syndrome.

Tomljenovic L, Shoenfeld Y.

Lancet Infect Dis. 2013 Jun 27. doi:pii: S1473-3099(13)70142-7. 10.1016/S1473- 3099(13)70142-7. [Epub ahead of print] No abstract available.

PMID: 23810251 [PubMed - as supplied by publisher]

Related citations

Select item 23810225 62.

Immune response to hepatitis B vaccine in a group of health care workers in Sri Lanka.

Chathuranga LS, Noordeen F, Abeykoon AM.

Int J Infect Dis. 2013 Jun 27. doi:pii: S1201-9712(13)00177-X. 10.1016/j.ijid.2013.04.009. [Epub ahead of print]

PMID: 23810225 [PubMed - as supplied by publisher]

Related citations

Select item 23810001 63.

Pharmacovigilance monitoring of a cohort of pregnant women vaccinated against influenza A(H1N1) variant virus in the Nord-Pas de Calais region of northern France.

Auffret M, Béné J, Gautier S, Moreau-Crépeaux S, Caron J.

Eur J Obstet Gynecol Reprod Biol. 2013 Jun 25. doi:pii: S0301-2115(13)00256-X. 10.1016/j.ejogrb.2013.05.025. [Epub ahead of print]

PMID: 23810001 [PubMed - as supplied by publisher]

Related citations

Select item 23809741 64.

Adverse Events with the Influenza A(H1N1) Vaccine Pandemrix® at Healthcare Professionals in Portugal.

Marques JI, Ribeiro Vaz I, Santos C, Polónia J.

Acta Med Port. 2013 Mar-Apr;26(2):107-12. Epub 2013 May 31.

PMID: 23809741 [PubMed - in process]

Related citations

Select item 23809613 65.

Missed Opportunities for Adolescent Vaccination, 2006-2011.

Wong CA, Taylor JA, Wright JA, Opel DJ, Katzenellenbogen RA.

J Adolesc Health. 2013 Jun 25. doi:pii: S1054-139X(13)00277-2. 10.1016/j.jadohealth.2013.05.009. [Epub ahead of print]

PMID: 23809613 [PubMed - as supplied by publisher]

Related citations

Select item 23809562 66.

Tuberculosis vaccine trials - Authors' reply.

Tameris M, Hatherill M, Mahomed H, McShane H.

Lancet. 2013 Jun 29;381(9885):2254. doi: 10.1016/S0140-6736(13)61483-X. No abstract available.

PMID: 23809562 [PubMed - in process]

Related citations

Select item 23809561 67.

Tuberculosis vaccine trials.

Upadhyay P.

Lancet. 2013 Jun 29;381(9885):2253-4. doi: 10.1016/S0140-6736(13)61482-8. No abstract available.

PMID: 23809561 [PubMed - in process]

Related citations

Select item 23809560 68.

Tuberculosis vaccine trials.

Behr MA, Schwartzman K, Pai M.

Lancet. 2013 Jun 29;381(9885):2252-3. doi: 10.1016/S0140-6736(13)61481-6. No abstract available.

PMID: 23809560 [PubMed - in process]

Related citations

Select item 23809262 69.

Viral vaccines: past successes and future challenges.

Ahmed R, Burton DR.

Curr Opin Virol. 2013 Jun 25. doi:pii: S1879-6257(13)00101-6. 10.1016/j.coviro.2013.06.007. [Epub ahead of print] No abstract available.

PMID: 23809262 [PubMed - as supplied by publisher]

Related citations

Select item 23808860 70.

Health Care Providers' Perspectives on Low HPV Vaccine Uptake and Adherence in Appalachian Kentucky.

Head KJ, Vanderpool RC, Mills LA.

Public Health Nurs. 2013 Jul;30(4):351-60. doi: 10.1111/phn.12044. Epub 2013 Apr 8.

PMID: 23808860 [PubMed - in process]

Related citations

Select item 23807400 71.

[The German Standing Committee on Vaccination and its new methodological approach].

Leidel J, Wichmann O.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Jul;56(7):901-2. doi: 10.1007/s00103-013-1765-7. German. No abstract available.

PMID: 23807400 [PubMed - in process]

Related citations

Select item 23807364 72.

Acute immune thrombocytopenic purpura as adverse reaction to oral polio vaccine (OPV).

Jin CQ, Dong HX, Sun ZX, Zhou JW, Dou CY, Lu SH, Yang RR.

Hum Vaccin Immunother. 2013 Jun 4;9(8). [Epub ahead of print]

PMID: 23807364 [PubMed - as supplied by publisher]

Related citations

Select item 23807362 73.

Association between microRNA polymorphisms and humoral immunity to hepatitis B vaccine.

Xiong Y, Chen S, Chen R, Lin W, Ni J.

Hum Vaccin Immunother. 2013 Jun 4;9(8). [Epub ahead of print]

PMID: 23807362 [PubMed - as supplied by publisher]

Related citations

Select item 23807361 74.

Utilizing health information technology to improve vaccine communication and coverage.

Stockwell MS, Fiks AG.

Hum Vaccin Immunother. 2013 Jun 4;9(8). [Epub ahead of print]

PMID: 23807361 [PubMed - as supplied by publisher]

Related citations

Select item 23807360 75.

Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: Randomized, double-blind, placebo-controlled Phase I studies.

Li RC, Li YP, Mo ZJ, Luo D, Huang T, Kong JL, Wang LH, Song NS, Liu A, Zhang H, Liao X, Karkada N, Han HH.

Hum Vaccin Immunother. 2013 Jun 4;9(8). [Epub ahead of print]

PMID: 23807360 [PubMed - as supplied by publisher]

Related citations

Select item 23807359 76.

How society should respond to the risk of vaccine rejection.

Ropeik D.

Hum Vaccin Immunother. 2013 Jun 6;9(8). [Epub ahead of print]

PMID: 23807359 [PubMed - as supplied by publisher]

Related citations

Select item 23807343 77.

[The second expedition of Balmis: revolution and vaccine].

Tuells J, Duro Torrijos JL.

Gac Med Mex. 2013 May-Jun;149(3):377-84. Spanish.

PMID: 23807343 [PubMed - in process]

Related citations

Select item 23807272 78.

Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.

Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa JP, Adbul-Jauwad H, Joseph P, Koenig E, Metzger D, Sobieszycz M, Tyndall M, Zorilla C.

AIDS. 2013 Jul 17;27(11):1763-1770.

PMID: 23807272 [PubMed - as supplied by publisher]

Related citations

Select item 23807079 79.

Low immunogenicity predicted for emerging avian-origin H7N9: Implication for influenza vaccine design.

De Groot AS, Ardito M, Terry F, Levitz L, Ross TM, Moise L, Martin W.

Hum Vaccin Immunother. 2013 May 1;9(5). [Epub ahead of print]

PMID: 23807079 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 23806899 80.

Vaccinations for healthcare personnel: update on influenza, hepatitis B, and pertussis.

Kaltsas A, Sepkowitz K.

Curr Opin Infect Dis. 2013 Aug;26(4):366-77. doi: 10.1097/QCO.0b013e3283630ee5.

PMID: 23806899 [PubMed - in process]

Related citations

Select item 23806698 81.

Hepatitis B vaccination status among healthcare workers in a tertiary care hospital in Tripoli, Libya.

Ziglam H, El-Hattab M, Shingheer N, Zorgani A, Elahmer O.

J Infect Public Health. 2013 Aug;6(4):246-51. doi: 10.1016/j.jiph.2013.02.001. Epub 2013 Apr 25.

PMID: 23806698 [PubMed - in process]

Related citations

Select item 23806539 82.

An Inactivated Hepatitis C Virus Vaccine on the Horizon?

Houghton M, Law J, Tyrrell DL.

Gastroenterology. 2013 Jun 24. doi:pii: S0016-5085(13)00931-1. 10.1053/j.gastro.2013.06.029. [Epub ahead of print] No abstract available.

PMID: 23806539 [PubMed - as supplied by publisher]

Related citations

Select item 23806515 83.

Advances in structure-based vaccine design.

Kulp DW, Schief WR.

Curr Opin Virol. 2013 Jun 24. doi:pii: S1879-6257(13)00070-9. 10.1016/j.coviro.2013.05.010. [Epub ahead of print]

PMID: 23806515 [PubMed - as supplied by publisher]

Related citations

Select item 23806507 84.

[Vaccination status of family physicians in the Loire district, France.]

Paya N, Pozzetto B, Berthelot P, Vallée J.

Med Mal Infect. 2013 Jun 24. doi:pii: S0399-077X(13)00160-1. 10.1016/j.medmal.2013.05.006. [Epub ahead of print] French.

PMID: 23806507 [PubMed - as supplied by publisher]

Related citations

Select item 23806328 85.

A Novel Method to Value Real Options in Health Care: The Case of a Multicohort Human Papillomavirus Vaccination Strategy.

Favato G, Baio G, Capone A, Marcellusi A, Saverio Mennini F.

Clin Ther. 2013 Jun 24. doi:pii: S0149-2918(13)00237-3. 10.1016/j.clinthera.2013.05.003. [Epub ahead of print]

PMID: 23806328 [PubMed - as supplied by publisher]

Related citations

Select item 23806267 86.

Race and Sex-Based Differences in Cytokine Immune Responses to Smallpox Vaccine in Healthy Individuals.

Haralambieva IH, Ovsyannikova IG, Kennedy RB, Larrabee BR, Shane Pankratz V, Poland GA.

Hum Immunol. 2013 Jun 24. doi:pii: S0198-8859(13)00188-2. 10.1016/j.humimm.2013.06.031. [Epub ahead of print]

PMID: 23806267 [PubMed - as supplied by publisher]

Related citations

Select item 23806243 87.

Self-report compared to electronic medical record across eight adult vaccines: Do results vary by demographic factors?

Rolnick SJ, Parker ED, Nordin JD, Hedblom BD, Wei F, Kerby T, Jackson JM, Crain AL, Euler G.

Vaccine. 2013 Jun 24. doi:pii: S0264-410X(13)00819-0. 10.1016/j.vaccine.2013.06.041. [Epub ahead of print]

PMID: 23806243 [PubMed - as supplied by publisher]

Related citations

Select item 23806242 88.

Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners: A 2010 survey.

Pulcini C, Massin S, Launay O, Verger P.

Vaccine. 2013 Jun 24. doi:pii: S0264-410X(13)00817-7. 10.1016/j.vaccine.2013.06.039. [Epub ahead of print]

PMID: 23806242 [PubMed - as supplied by publisher]

Related citations

Select item 23806241 89.

Cost-effectiveness of the prophylactic HPV vaccine: An application to the Netherlands taking non-cervical cancers and cross-protection into account.

Luttjeboer J, Westra TA, Wilschut JA, Nijman HW, Daemen T, Postma MJ.

Vaccine. 2013 Jun 24. doi:pii: S0264-410X(13)00823-2. 10.1016/j.vaccine.2013.06.044. [Epub ahead of print]

PMID: 23806241 [PubMed - as supplied by publisher]

Related citations

Select item 23806240 90.

Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults.

Smith KJ, Nowalk MP, Raymund M, Zimmerman RK.

Vaccine. 2013 Jun 24. doi:pii: S0264-410X(13)00815-3. 10.1016/j.vaccine.2013.06.037. [Epub ahead of print]

PMID: 23806240 [PubMed - as supplied by publisher]

Related citations

Select item 23806224 91.

Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination.

Müller RB, Maier R, Hoschler K, Zambon M, Ludewig B, Herrmann M, Schulze-Koops H, von Kempis J.

Clin Exp Rheumatol. 2013 Jun 14. [Epub ahead of print]

PMID: 23806224 [PubMed - as supplied by publisher]

Related citations

Select item 23805959 92.

Establishing the safety of influenza vaccine in egg-allergic individuals.

Greenhawt MJ.

Pediatr Ann. 2013 Jul 1;42(7):122-7. doi: 10.3928/00904481-20130619-09.

PMID: 23805959 [PubMed - in process]

Related citations

Select item 23805679 93.

[Experience of application of pneumococcus vaccines for studies of humoral immunity].

[No authors listed]

Zh Mikrobiol Epidemiol Immunobiol. 2013 Mar-Apr;(2):96-101. Russian.

PMID: 23805679 [PubMed - in process]

Related citations

Select item 23805659 94.

[Vaccine prophylaxis of varicella: tactics and perspectives].

[No authors listed]

Zh Mikrobiol Epidemiol Immunobiol. 2013 Jan-Feb;(1):85-8. Russian. No abstract available.

PMID: 23805659 [PubMed - in process]

Related citations

Select item 23805653 95.

[Progress, problems and objectives in the field of vaccine prophylaxis of infectious diseases].

[No authors listed]

Zh Mikrobiol Epidemiol Immunobiol. 2013 Jan-Feb;(1):59-61. Russian. No abstract available.

PMID: 23805653 [PubMed - in process]

Related citations

Select item 23805542 96.

A DNA vaccine expressing ENV and GAG offers partial protection against reticuloendotheliosis virus in the prairie chicken (Tympanicus cupido).

Drechsler Y, Tkalcic S, Saggese MD, Shivaprasad HL, Ajithdoss DK, Collisson EW.

J Zoo Wildl Med. 2013 Jun;44(2):251-61.

PMID: 23805542 [PubMed - in process]

Related citations

Select item 23777700 97.

Temporal trends in diarrhea-related hospitalizations and deaths in children under age 5 before and after the introduction of the rotavirus vaccine in four Latin American countries.

De Oliveira LH, Giglio N, Ciapponi A, Martí SG, Kuperman M, Sanwogou NJ, Ruiz-Matus C, Marinho de Sousa MF.

Vaccine. 2013 Jul 2;31 Suppl 3:C99-C108. doi: 10.1016/j.vaccine.2013.05.065.

PMID: 23777700 [PubMed - in process]

Related citations

Select item 23777699 98.

Critical issues in implementing a national integrated all-vaccine preventable disease surveillance system.

Hyde TB, Andrus JK, Dietz VJ; Integrated All-VPD Surveillance Working Group.

Vaccine. 2013 Jul 2;31 Suppl 3:C94-8. doi: 10.1016/j.vaccine.2013.05.034.

PMID: 23777699 [PubMed - in process]

Related citations

Select item 23777698 99.

Cost analysis of an integrated vaccine-preventable disease surveillance system in Costa Rica.

Toscano CM, Vijayaraghavan M, Salazar-Bolaños HM, Bolaños-Acuña HM, Ruiz- González AI, Barrantes-Solis T, Fernández-Vargas I, Panero MS, de Oliveira LH, Hyde TB; iVPD Working Team.

Vaccine. 2013 Jul 2;31 Suppl 3:C88-93. doi: 10.1016/j.vaccine.2013.05.036.

PMID: 23777698 [PubMed - in process]

Related citations

Select item 23777697 100.

Systematic review of incremental non-vaccine cost estimates used in cost- effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines.

De la Hoz-Restrepo F, Castañeda-Orjuela C, Paternina A, Alvis-Guzman N.

Vaccine. 2013 Jul 2;31 Suppl 3:C80-7. doi: 10.1016/j.vaccine.2013.05.064.

PMID: 23777697 [PubMed - in process]

Related citations

Select item 23777696 101.

Perspectives on sustainable vaccine introduction.

Hinman AR.

Vaccine. 2013 Jul 2;31 Suppl 3:C8-9. doi: 10.1016/j.vaccine.2013.05.053. No abstract available.

PMID: 23777696 [PubMed - in process]

Related citations

Select item 23777693 102.

What do policy makers need to know? Lessons from the decision to add pneumococcal conjugate and rotavirus vaccines to the US immunization program.

Whitney CG, Parashar UD.

Vaccine. 2013 Jul 2;31 Suppl 3:C6-7. doi: 10.1016/j.vaccine.2013.05.051. No abstract available.

PMID: 23777693 [PubMed - in process]

Related citations

Select item 23777690 103.

Historical perspectives on new vaccine introduction in Latin America and the Caribbean. de Quadros C.

Vaccine. 2013 Jul 2;31 Suppl 3:C4-5. doi: 10.1016/j.vaccine.2013.05.058. No abstract available.

PMID: 23777690 [PubMed - in process]

Related citations

Select item 23777687 104.

Evidence base for new vaccine introduction in Latin America and the Caribbean.

Andrus JK, Walker DG.

Vaccine. 2013 Jul 2;31 Suppl 3:C2-3. doi: 10.1016/j.vaccine.2013.05.074. No abstract available.

PMID: 23777687 [PubMed - in process]

Related citations

Select item 23777686 105.

TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.

Clark A, Jauregui B, Griffiths U, Janusz CB, Bolaños-Sierra B, Hajjeh R, Andrus JK, Sanderson C.

Vaccine. 2013 Jul 2;31 Suppl 3:C19-29. doi: 10.1016/j.vaccine.2013.05.045.

PMID: 23777686 [PubMed - in process]

Related citations

Select item 23777685 106.

Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: The ProVac experience.

Toscano CM, Jauregui B, Janusz CB, Sinha A, Clark AD, Sanderson C, Resch S, Matus CR, Andrus JK; ProVac Network of Centers of Excellence.

Vaccine. 2013 Jul 2;31 Suppl 3:C12-8. doi: 10.1016/j.vaccine.2013.05.033.

PMID: 23777685 [PubMed - in process] 37

Related citations

Select item 23777684 107.

Systematic documentation of new vaccine introduction in selected countries of the Latin American Region. de Oliveira LH, Toscano CM, Sanwogou NJ, Ruiz-Matus C, Tambini G, Roses-Periago M, Andrus JK.

Vaccine. 2013 Jul 2;31 Suppl 3:C114-22. doi: 10.1016/j.vaccine.2013.05.032.

PMID: 23777684 [PubMed - in process]

Related citations

Select item 23777683 108.

Effectiveness of the 7-valent pneumococcal conjugate vaccine against vaccine-type invasive disease among children in Uruguay: An evaluation using existing data.

Picón T, Alonso L, García Gabarrot G, Speranza N, Casas M, Arrieta F, Camou T, Rosa R, Helena De Oliveira L, Verani JR.

Vaccine. 2013 Jul 2;31 Suppl 3:C109-13. doi: 10.1016/j.vaccine.2013.01.059.

PMID: 23777683 [PubMed - in process]

Related citations

Select item 23777682 109.

Beyond methods and studies: Building institutions for better public spending on vaccination.

Glassman A.

Vaccine. 2013 Jul 2;31 Suppl 3:C10-1. doi: 10.1016/j.vaccine.2013.05.050. No abstract available.

PMID: 23777682 [PubMed - in process]

Related citations

AMEDEO - Vaccines Publicaciones (01 - 07 - 2013): 28 artículos nuevos.

Vacunas Neumococo (Streptococcus pneumoniae)

3. DAGAN R, Patterson S, Juergens C, Greenberg D, et al. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccine in reducing nasopharyngeal colonization: a randomized double-blind trial. Clin Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=23804191&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23804191

4. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6-18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2013;62:521-4. PubMed: www.amedeo.com/p2.php?id=23803961&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23803961

5. NAKAMURA R, Togashi T. Population-Based Incidence of Invasive Haemophilus influenzae and Pneumococcal Diseases before the Introduction of Vaccines in Japan. Pediatr Infect Dis J. 2013. PubMed: www.amedeo.com/p2.php?id=23804122&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23804122

10. SMITH KJ, Nowalk MP, Raymund M, Zimmerman RK, et al. Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults. Vaccine. 2013 Jun 24. pii: S0264-410X(13)00815. PubMed: www.amedeo.com/p2.php?id=23806240&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23806240

14. DE LA HOZ-RESTREPO F, Castaneda-Orjuela C, Paternina A, Alvis-Guzman N, et al. Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines. Vaccine. 2013;31 Suppl 3:C80-7. PubMed: www.amedeo.com/p2.php?id=23777697&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23777697

16. WHITNEY CG, Parashar UD. What do policy makers need to know? Lessons from the decision to add pneumococcal conjugate and rotavirus vaccines to the US immunization program. Vaccine. 2013;31 Suppl 3:C6-7. PubMed: www.amedeo.com/p2.php?id=23777693&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/23777693

19. CLARK A, Jauregui B, Griffiths U, Janusz CB, et al. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination. Vaccine. 2013;31 Suppl 3:C19-29. PubMed: www.amedeo.com/p2.php?id=23777686&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23777686

22. PICON T, Alonso L, Garcia Gabarrot G, Speranza N, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine against vaccine-type invasive disease among children in Uruguay: An evaluation using existing data. Vaccine. 2013;31 Suppl 3:C109-13. PubMed: www.amedeo.com/p2.php?id=23777683&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23777683

Vacunas, otras

1. NOVAK RM, Metch B, Buchbinder S, Cabello R, et al. Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition. AIDS. 2013;27:1763-1770. PubMed: www.amedeo.com/p2.php?id=23807272&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23807272

2. BLOMBERG M, Dehlendorff C, Munk C, Kjaer SK, et al. Strongly decreased risk of genital warts after vaccination against HPV. Nationwide follow-up of vaccinated and unvaccinated girls in Denmark. Clin Infect Dis. 2013. PubMed: www.amedeo.com/p2.php?id=23804192&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23804192

6. HARDY-FAIRBANKS AJ, Pan SJ, Decker MD, Johnson DR, et al. Immune Responses in Infants Whose Mothers Received Tdap Vaccine During

Pregnancy. Pediatr Infect Dis J. 2013. PubMed: www.amedeo.com/p2.php?id=23799518&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23799518

7. ROLNICK SJ, Parker ED, Nordin JD, Hedblom BD, et al. Self-report compared to electronic medical record across eight adult vaccines: Do results vary by demographic factors? Vaccine. 2013 Jun 24. pii: S0264-410X(13)00819. PubMed: www.amedeo.com/p2.php?id=23806243&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23806243

8. PULCINI C, Massin S, Launay O, Verger P, et al. Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners: A 2010 survey. Vaccine. 2013 Jun 24. pii: S0264-410X(13)00817. PubMed: www.amedeo.com/p2.php?id=23806242&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23806242

9. LUTTJEBOER J, Westra TA, Wilschut JA, Nijman HW, et al. Cost-effectiveness of the prophylactic HPV vaccine: An application to the Netherlands taking non-cervical cancers and cross-protection into account. Vaccine. 2013 Jun 24. pii: S0264-410X(13)00823. PubMed: www.amedeo.com/p2.php?id=23806241&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23806241

11. DE OLIVEIRA LH, Giglio N, Ciapponi A, Marti SG, et al. Temporal trends in diarrhea-related hospitalizations and deaths in children under age 5 before and after the introduction of the rotavirus vaccine in four Latin American countries. Vaccine. 2013;31 Suppl 3:C99-C108. PubMed: www.amedeo.com/p2.php?id=23777700&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23777700

12. HYDE TB, Andrus JK, Dietz VJ. Critical issues in implementing a national integrated all-vaccine preventable disease surveillance system. Vaccine. 2013;31 Suppl 3:C94-8. PubMed: www.amedeo.com/p2.php?id=23777699&s=vac&pm=badc2a9eebb0fad ABSTRACT available

Share: http://m.amedeo.com/23777699

13. TOSCANO CM, Vijayaraghavan M, Salazar-Bolanos HM, Bolanos-Acuna HM, et al. Cost analysis of an integrated vaccine-preventable disease surveillance system in Costa Rica. Vaccine. 2013;31 Suppl 3:C88-93. PubMed: www.amedeo.com/p2.php?id=23777698&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23777698

15. HINMAN AR. Perspectives on sustainable vaccine introduction. Vaccine. 2013;31 Suppl 3:C8-9. PubMed: www.amedeo.com/p2.php?id=23777696&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/23777696

Share: http://m.amedeo.com/23777693

17. DE QUADROS C. Historical perspectives on new vaccine introduction in Latin America and the Caribbean. Vaccine. 2013;31 Suppl 3:C4-5. PubMed: www.amedeo.com/p2.php?id=23777690&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/23777690

18. ANDRUS JK, Walker DG. Evidence base for new vaccine introduction in Latin America and the Caribbean. Vaccine. 2013;31 Suppl 3:C2-3. PubMed: www.amedeo.com/p2.php?id=23777687&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/23777687

PubMed: www.amedeo.com/p2.php?id=23777686&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23777686

20. TOSCANO CM, Jauregui B, Janusz CB, Sinha A, et al. Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: The ProVac experience. Vaccine. 2013;31 Suppl 3:C12-8. PubMed: www.amedeo.com/p2.php?id=23777685&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23777685

21. DE OLIVEIRA LH, Toscano CM, Sanwogou NJ, Ruiz-Matus C, et al. Systematic documentation of new vaccine introduction in selected countries of the Latin American Region. Vaccine. 2013;31 Suppl 3:C114-22. PubMed: www.amedeo.com/p2.php?id=23777684&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23777684

23. GLASSMAN A. Beyond methods and studies: Building institutions for better public spending on vaccination. Vaccine. 2013;31 Suppl 3:C10-1. PubMed: www.amedeo.com/p2.php?id=23777682&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/23777682

24. COLEMAN JK, Pu R, Martin MM, Noon-Song EN, et al. Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies: Efficacy and potential prophylactic mechanism(s) of prototype and commercial FIV vaccines. Vaccine. 2013 Jun 22. pii: S0264-410X(13)00602. PubMed: www.amedeo.com/p2.php?id=23800540&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23800540

25. DURHAM DP, Mbah ML, Medlock J, Luz PM, et al. Dengue dynamics and vaccine cost-effectiveness in Brazil. Vaccine. 2013 Jun 20. pii: S0264-410X(13)00814. PubMed: www.amedeo.com/p2.php?id=23791696&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23791696

26. HOFSTETTER AM, Rosenthal SL. Health care professional communication about STI vaccines with adolescents and parents. Vaccine. 2013 Jun 20. pii: S0264-410X(13)00813. PubMed: www.amedeo.com/p2.php?id=23791695&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23791695

27. BATTEN CA, Edwards L, Oura CA. Evaluation of the humoral immune responses in adult cattle and sheep, 4 and 2.5 years post-vaccination with a bluetongue serotype 8 inactivated vaccine. Vaccine. 2013 Jun 19. pii: S0264-410X(13)00811. PubMed: www.amedeo.com/p2.php?id=23791548&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23791548

28. CONNIE LEUNG YH, Luk G, Sia SF, Wu YO, et al. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China. Vaccine. 2013 Jun 19. pii: S0264-410X(13)00691. PubMed: www.amedeo.com/p2.php?id=23791547&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23791547

PATENTES

United States Patent and Trademark Office (USPTO)

Estrategia de búsqueda “vaccine” en título y abstract

(ABST/vaccine AND ISD/20130625->20130705): 4 patentes recuperadas.

Vacunas, otras

PAT. NO. Title

8,478,535 Systems and methods that utilize machine learning

algorithms to facilitate assembly of aids vaccine cocktails

2 8,475,807 Avian influenza virus live attenuated vaccine and uses

thereof

3 8,470,598 Modified Vaccinia Ankara virus variant and cultivation

method

4 8,470,560 CR-2 binding peptide P28 as molecular adjuvant for DNA

vaccines

European Patent Office (EPO)

Acumulado entre el 25 de junio y el 5 de julio de 2013: patentes recuperadas.

Adyuvantes

6. VACCINE COMPOSITIONS COMPRISING A SAPONIN ADJUVANT

Publication info: NZ596870 (A) 2013-06-28

Vacunas, otras

1. ROTAVIRUS VACCINE

SI1660123 (T1) 2013-06-28 Publication info:

2. POROUS DEGRADABLE POLYELECTROLYTE MICROSPHERES AS VACCINE VECTOR

EP2608774 (A1) 2013-07-03 Publication info:

3. AN EPSTEIN-BARR-VIRUS VACCINE

EP2608806 (A1) 2013-07-03 Publication info:

4. POTENCY TEST FOR VACCINE FORMULATIONS

EP2609428 (A1) 2013-07-03 Publication info:

5. ANIMAL MODEL FOR THE EVALUATION OF THE EFFICACY OF AN HIV VACCINE

EP2608661 (A1) 2013-07-03 Publication info:

6. VACCINE COMPOSITIONS COMPRISING A SAPONIN ADJUVANT

NZ596870 (A) 2013-06-28 Publication info:

7. Improvements in the preparation of influenza virus vaccine antigens utilising a phosphate buffer

NZ587798 (A) 2013-06-28 Publication info:

8. ROTAVIRUS VACCINE

HRP20130407 (T1) 2013-06-30 Publication info:

9. VACCINE - SCREENING METHOD

WO2013093512 (A2) 2013-06-27 Publication info:

10. CARIOUS TOOTH VACCINE AND PREPARATION METHOD

WO2013091260 (A1) 2013-06-27 Publication info:

11. BRUCELLA OVIS ATTENUATED STRAIN, VACCINE COMPOSITION AND USE

WO2013091040 (A2) 2013-06-27 Publication info:

12. LAWSONIA VACCINE AND METHODS OF USE THEREOF

US2013164332 (A1) 2013-06-27 Publication info:

13. HUMAN CYTOMEGALOVIRUS VACCINE

US2013164289 (A1) 2013-06-27 Publication info:

14. CANCER PEPTIDE VACCINE

US2013164314 (A1) 2013-06-27 Publication info:

15. Adenovirus vaccine vectors

US2013164327 (A1) 2013-06-27 Publication info:

TABLAS DE CONTENIDO

Revista Vaccine

New Articles in Press, 24 June-30 June 2013.

1. Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice Original Research Article

Available online 29 June 2013 Marietjie Venter, Petrus Jansen van Vuren, Juliet Mentoor, Janusz Paweska, June Williams

2. Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States Original Research Article

Available online 29 June 2013 Harrell W. Chesson, Donatus U. Ekwueme, Mona Saraiya, Eileen F. Dunne, Lauri E. Markowitz

3. Low pathogenic avian influenza A(H7N9) virus causes high mortality in ferrets upon intratracheal challenge: A model to study intervention strategies Original Research Article

Available online 28 June 2013 J.H.C.M. Kreijtz, E. Veldhuis Kroeze, K.J. Stittelaar, L. de Waal, G. van Amerongen, S. van Trierum, P. van Run, T. Bestebroer, T.Kuiken, R.A.M. Fouchier, G.F. Rimmelzwaan, A.D.M.E. Osterhaus

4. Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Hong Kong SAR, China, 24–26 January 2013

Available online 26 June 2013 Marc P. Girard, John S. Tam, Yuri Pervikov, Jacqueline M. Katz

5. Anti-HBs evaluation and booster dose in vaccinated healthcare students

Available online 26 June 2013 Michele Augusto Riva, Michele Sormani

6. Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners: A 2010 survey Original Research Article

Available online 24 June 2013 Céline Pulcini, Sophie Massin, Odile Launay, Pierre Verger

7. Cost–effectiveness of the prophylactic HPV vaccine: An application to the Netherlands taking non-cervical cancers and cross-protection into account

Original Research Article

Available online 24 June 2013 J. Luttjeboer, T.A. Westra, J.A. Wilschut, H.W. Nijman, T. Daemen, M.J. Postma

8. Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults Original Research Article

Available online 24 June 2013 Kenneth J. Smith, M. Patricia Nowalk, Mahlon Raymund, Richard K. Zimmerman

9. Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999–2010 Original Research Article

Available online 24 June 2013 Karen E. Lamb, Stefan Flasche, Mathew Diggle, Donald Inverarity, David Greenhalgh, Johanna M. Jefferies, Andrew Smith, Giles F.S. Edwards, Barbara Denham, Jim McMenamin, Eisin McDonald, Tim J. Mitchell, Stuart C. Clarke, Chris Robertson

10. Proteins as T cell antigens: Methods for high-throughput identification Review Article

Available online 24 June 2013 Daniel Grubaugh, Jessica Baker Flechtner, Darren E. Higgins

11. Self-report compared to electronic medical record across eight adult vaccines: Do results vary by demographic factors? Original Research Article

Available online 24 June 2013 S.J. Rolnick, E.D. Parker, J.D. Nordin, B.D. Hedblom, F. Wei, T. Kerby, J.M. Jackson, A.L. Crain, G. Euler

Vaccine, Volume 31, Issue 32, Pages 3207-3308, 11 July 2013.

1. Editorial Board/Aims and Scope

Pages CO2

Editorial

2. Submission of articles to Vaccine: A fast and fair peer review process

Pages 3207-3208 Floris de Hon, Gregory A. Poland

Meeting reports

3. Strengthening the influenza vaccine virus selection and development process: Outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conférences (CICG) Geneva, Switzerland, 7 to 9 December 2011

Pages 3209-3221 WHO Writing Group

4. Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30–December 1, 2012, Les Pensieres, Veyrier-du-Lac, France)

Pages 3222-3228 Bradford D. Gessner, W. Abdullah Brooks, Kathleen M. Neuzil, Guy Vernet, Rick A. Bright, John S. Tam, Joseph Bresee, Arnold S. Monto

Reviews

5. Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection Review Article

Pages 3229-3235 Victor A. Garcia-Angulo, Anjana Kalita, Alfredo G. Torres

6. Prospects for oral replicating adenovirus-vectored vaccines Review Article

Pages 3236-3243 Cailin Deal, Andrew Pekosz, Gary Ketner

Regular papers

7. Perceptions and acceptability of HPV vaccination among parents of young adolescents: A multicenter national survey in China Original Research Article

Pages 3244-3249 Shao-Kai Zhang, Xiong-Fei Pan, Shao-Ming Wang, Chun-Xia Yang, Xiao- Hong Gao, Zeng-Zhen Wang, Man Li, Ze-Fang Ren, Fang-Hui Zhao, You-Lin Qiao

8. Protective efficacy of vaccines based on the Helicobacter suis urease subunit B and γ-glutamyl transpeptidase Original Research Article

Pages 3250-3256 Miet Vermoote, Bram Flahou, Frank Pasmans, Richard Ducatelle, Freddy Haesebrouck

9. Transcutaneous immunization of healthy volunteers with an attenuated Listeria monocytogenes vaccine strain and cholera toxin adjuvant Original Research Article

Pages 3257-3261 Elizabeth H. Eypper, Paul V. Johnson, Eva I. Purro, Elizabeth L. Hohmann

10. Non-adjuvanted flagellin elicits a non-specific protective immune response in rainbow trout (Oncorhynchus mykiss, Walbaum) towards bacterial infections Original Research Article

Pages 3262-3267 Callum J.W. Scott, Brian Austin, Dawn A. Austin, Peter C. Morris

11. Virus-like particle vaccine protects against H3N2 canine influenza virus in dog Original Research Article

Pages 3268-3273 Dong-Hun Lee, Sang-Woo Bae, Jae-Keun Park, Jung-Hoon Kwon, Seong-Su Yuk, Jae-Min Song, Sang-Moo Kang, Yong-Kuk Kwon, Hwi-Yool Kim, Chang- Seon Song

12. Transposon leads to contamination of clinical pDNA vaccine Original Research Article

Pages 3274-3280 I. van der Heijden, R. Gomez-Eerland, J.H. van den Berg, K. Oosterhuis, T.N. Schumacher, J.B.A.G. Haanen, J.H. Beijnen, B. Nuijen

13. Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice Original Research Article

Pages 3281-3287 Hao-Yang Li, Jian-Feng Han, Cheng-Feng Qin, Rong Chen

14. Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice Original Research Article

Pages 3288-3294 A.I. Camacho, J.M. Irache, J. de Souza, S. Sánchez-Gómez, C. Gamazo

15. Expression of Clostridium perfringens epsilon-beta fusion toxin gene in E. coli and its immunologic studies in mouse Original Research Article

Pages 3295-3299 Reza Pilehchian Langroudi, Mehdi Shamsara, Khosrow Aghaiypour

16. Cost-effectiveness of rotavirus immunization in Indonesia: Taking breastfeeding patterns into account Original Research Article

Pages 3300-3307

Auliya A. Suwantika, Hong Anh T. Tu, Maarten J. Postma

